Letter by Suissa and Galié regarding article, "anticoagulation and survival in pulmonary arterial hypertension: Results from the comparative, prospective registry of newly initiated therapies for pulmonary hypertension (COMPERA)"

Circulation

Volumn 130, Issue 12, 2014, Pages e107-

  Suissa, Samy ^a,b   Galié, Nazzareno ^c,d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Department of Experimental Diagnostic and Specialty Medicine DIMES   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULANT THERAPY; ANTICOAGULATION; COHORT ANALYSIS; FOLLOW UP; HUMAN; LETTER; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REGISTER; SURVIVAL; FEMALE; HYPERTENSION, PULMONARY; MALE; THROMBOSIS;

ANTICOAGULANTS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; THROMBOSIS;

EID: 84927646649     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.007666     Document Type: Letter

References (3)

1. Olsson KM, Delcroix M, Ghofrani HA, Tiede H, Huscher D, Speich R, Grünig E, Staehler G, Rosenkranz S, Halank M, Held M, Lange TJ, Behr J, Klose H, Claussen M, Ewert R, Opitz CF, Vizza CD, Scelsi L, Vonk-Noordegraaf A, Kaemmerer H, Gibbs JS, Coghlan G, Pepke-Zaba J, Schulz U, Gorenflo M, Pittrow D, Hoeper MM. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Circulation. 2014;129:57-65.
2. Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf. 2007;16:241-249.
3. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol. 2008;167:492-499.